The influence of introducing unrestricted access to sugammadex and quantitative neuromuscular monitors on the incidence of residual neuromuscular block at a tertiary teaching hospital. An audit of 'real-life'.
Registrar, Anaesthesia and Pain Medicine, Royal Perth Hospital, Perth, Western Australia.
J I
JI
Milne
Registrar, Anaesthesia and Pain Medicine, Royal Perth Hospital, Perth, Western Australia.
C S
CS
Ong
Resident Medical Officer, Anaesthesia and Pain Medicine, Royal Perth Hospital, Perth, Western Australia.
J S
JS
Ong
Resident Medical Officer, Anaesthesia and Pain Medicine, Royal Perth Hospital, Perth, Western Australia.
K C
KC
Cheung
Resident Medical Officer, Anaesthesia and Pain Medicine, Royal Perth Hospital, Perth, Western Australia.
A A
AA
Schauer
Resident Medical Officer, Anaesthesia and Pain Medicine, Royal Perth Hospital, Perth, Western Australia.
S B
SB
Buttar
Consultant Anaesthetist, Department of Anaesthesia and Pain Medicine, Royal Perth Hospital, Wellington Street Campus, Perth, Western Australia.
T
T
Ledowski
D006784:Hospitals, Teaching; D006801:Humans; D008991:Monitoring, Physiologic / Q000295:instrumentation*; D019148:Neuromuscular Blockade; D009469:Neuromuscular Junction / Q000502:physiology*; D000077122:Sugammadex; D047408:gamma-Cyclodextrins / Q000494:pharmacology*
D047408:gamma-Cyclodextrins; D000077122:Sugammadex